These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9499338)

  • 1. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Manoharan A
    Ann Intern Med; 1998 Mar; 128(6):504; author reply 504-5. PubMed ID: 9499338
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring warfarin therapy in patients with lupus anticoagulants.
    D'Angelo A; Della Valle P; Crippa L
    Ann Intern Med; 1998 Mar; 128(6):504-5. PubMed ID: 9499339
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring warfarin therapy in patients with lupus anticoagulants (LA).
    Tripodi A; Mannucci PM
    Thromb Haemost; 1998 Aug; 80(2):349-50. PubMed ID: 9716171
    [No Abstract]   [Full Text] [Related]  

  • 5. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
    Crowl A; Schullo-Feulner A; Moon JY
    Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban and false positive lupus anticoagulant testing.
    Merriman E; Kaplan Z; Butler J; Malan E; Gan E; Tran H
    Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666
    [No Abstract]   [Full Text] [Related]  

  • 7. Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation.
    Ketha SS; Pruthi RK; McBane RD; Wysokinski WE
    J Thromb Thrombolysis; 2014 May; 37(4):532-5. PubMed ID: 23743990
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiphospholipid antibody and anesthesia.
    Kone A
    Acta Anaesthesiol Belg; 2003; 54(2):169-71. PubMed ID: 12872437
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary antiphospholipid syndrome with recurrent transient ischemic attacks: report of a case and its successful treatment.
    Ihara M; Tanaka H; Nishimura Y
    Intern Med; 1998 Aug; 37(8):704-7. PubMed ID: 9745860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):242-4. PubMed ID: 20182349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
    Rosborough TK; Shepherd MF
    Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
    Moore GW; Smith MP; Savidge GF
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):307-12. PubMed ID: 12695757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsurgery in the hypercoagulable patient: review of the literature.
    Herrera FA; Lee CK; Kryger G; Roostaeian J; Safa B; Lohman RF; Gottlieb LJ; Walton RL
    J Reconstr Microsurg; 2012 Jun; 28(5):305-12. PubMed ID: 22547257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Premature cardiovascular disease: no indication for the determination of antiphospholipid antibodies or lupus anticoagulant as a possible risk factor].
    Wierema TK; Stehouwer CD
    Ned Tijdschr Geneeskd; 2007 Mar; 151(13):735-8. PubMed ID: 17471773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants.
    Kershaw G
    Methods Mol Biol; 2017; 1646():75-83. PubMed ID: 28804819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
    Baquero-Salamanca M; Téllez-Arévalo AM; Calderon-Ospina C
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25858939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hughes syndrome.
    Sivaprasad S; Gregor Z
    Clin Exp Ophthalmol; 2007 Jul; 35(5):496-8. PubMed ID: 17651260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
    Di Giacomo TB; Hussein TP; Souza DG; Criado PR
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin home monitoring program expanded.
    Harv Heart Lett; 2008 Jun; 18(10):7. PubMed ID: 18822511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.